1-7 of 7
Zhi Yang
Close
Sort by
Journal Articles

Lisocabtagene Maraleucel as Second-Line Therapy for R/R Large B-Cell Lymphoma in Patients Not Intended for Hematopoietic Stem Cell Transplant: Final Analysis of the Phase 2 PILOT Study

Alison R Sehgal, Daanish Hoda, Peter A Riedell, Nilanjan Ghosh, Mehdi Hamadani, Gerhard Hildebrandt, John E. Godwin, Patrick M. Reagan, Nina Wagner-Johnston, James Essell, Rajneesh Nath, Scott R. Solomon, Rebecca Champion, Edward Licitra, Suzanne Fanning, Neel K. Gupta, Victor A Chow, Brenda Yuan, Zhi Yang, Ken Ogasawara, Jerill Thorpe, Leo I. Gordon
Journal: Blood
Blood (2023) 142 (Supplement 1): 105.
https://doi.org/10.1182/blood-2023-180952
Published: 2023
Journal Articles

Clinical Characteristics and Prognosis of Acute Myeloid Leukemia Patients with Protein Tyrosine Phosphatase Non-Receptor Type 11 Gene Mutation

Weihua Zhao, Rui Huang, Yiting Zhang, Yu Lin, Ruli Pang, Zhi Yang
Journal: Blood
Blood (2023) 142 (Supplement 1): 5863.
https://doi.org/10.1182/blood-2023-184840
Published: 2023
Journal Articles

A Novel Platform to Manufacture High-Efficient "Off-the-Shelf" CAR-NK Products from Peripheral Blood Mononuclear Cells (PBMC)

Yukang Huang, Yunfan Chen, Junjie Shen, Yanmin Xu, Yanan Qi, Zhi Yang, Qianzhen Zhang, Jun Chen, Wenxu Zhao, Juan Hong, Jingwen Hu, Liurong Jiao, Qiushuang Zhu, Linling Wang, Yongchun Zhao, Xia Huang, Lei Qin, Ruina Yao, Depeng Dai, Yunyan Li, Meiling Wang, Cheng Qian
Journal: Blood
Blood (2022) 140 (Supplement 1): 7409–7410.
https://doi.org/10.1182/blood-2022-162937
Published: 2022
Journal Articles

The Safety and Efficacy of p CAR-19B, a Scfv Humanlized CD19-Directed CAR-T for Patients with Relapsed/Refactory (R/R) CD19+ B-ALL

Zhenya Hong, Zhi Yang, Xiaoxi Zhou, Gaoxiang Wang, Mi Zhou, Yingzi Zhang, Peiling Zhang, Jinjin Huang, Li Meng, Haitao Ruan, Min Xiao, Yunyan Li, Linling Wang, Meiling Wang, Wei Zhu, Qianzhen Zhang, Junjie Shen, Jianfeng Zhou, Cheng Qian, Liang Huang
Journal: Blood
Blood (2022) 140 (Supplement 1): 4625–4626.
https://doi.org/10.1182/blood-2022-162134
Published: 2022
Journal Articles

Evaluation of XL999, a Potent Inhibitor of FGFR3, for the Potential Treatment of t(4;14) Positive Multiple Myeloma.

Suzanne Trudel, MD, Xiu Zhi Yang, MD, Zhi Hua Li, MD, Sheng-ben Liang, PhD, Dana T. Aftab, PhD
Journal: Blood
Blood (2007) 110 (11): 2515.
https://doi.org/10.1182/blood.V110.11.2515.2515
Published: 2007
Journal Articles

Oncolytic Virotherapy for Multiple Myeloma.

Judith Andrea McCart, MD, Hui Deng, Nan Tang, MSc, Gillian Sleep, Navneet Mehta, MSc, Amaalia Stief, Xiu-Zhi Yang, Kimberly Cottick, Colin McKerlie, Suzanne Trudel, MD, Keith Stewart, MD
Journal: Blood
Blood (2006) 108 (11): 3486.
https://doi.org/10.1182/blood.V108.11.3486.3486
Published: 2006
Journal Articles

The Characterization, Molecular Cloning, and Expression of a Novel Hematopoietic Cell Antigen From CD34 + Human Bone Marrow Cells

Nobuko Uchida, Zhi Yang, Jesse Combs, Olivier Pourquié, Megan Nguyen, Rajeev Ramanathan, Joan Fu, Annemarie Welply, Shirley Chen, Greg Weddell, Arun K. Sharma, Kevin R. Leiby, Domna Karagogeos, Beth Hill, Laurent Humeau, William B. Stallcup, Ron Hoffman, Ann S. Tsukamoto, David P. Gearing, Bruno Péault
Journal: Blood
Blood (1997) 89 (8): 2706–2716.
https://doi.org/10.1182/blood.V89.8.2706
Published: 1997